Which has the lower trailing P/E, BIIB or WAT?

BIIB has the lower trailing P/E: BIIB trades at 38.56 and WAT at 105.25. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIIB or WAT?

Over the past five years, WAT grew revenue faster — BIIB at a -3.19% CAGR versus WAT at 11.70%.

Is BIIB or WAT more profitable?

BIIB runs the higher net margin — BIIB at 8.39% versus WAT at 3.58%.

How have BIIB and WAT total returns compared?

Over the past 10 years, BIIB delivered -3.05% and WAT delivered 10.36% annualized total return. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs Waters Corporation (WAT)

A side-by-side comparison of Biogen Inc. and Waters Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BIIB

Biogen Inc.

$32.19B

$217.86HealthcareDelayed quote: Sep 21, 2026, 10:15 AM EDT

WAT

Waters Corporation

$31.57B

$422.06HealthcareDelayed quote: Sep 21, 2026, 10:15 AM EDT

Total return — BIIB vs WAT

growth of $100 · dividends reinvested · last 10y

BIIB -27.2% (-3.1%/yr)WAT +161.7% (+10.1%/yr)WAT compounded faster over this window

BIIB WAT

BIIB vs WAT: by the numbers

•BIIB is the larger company ($32.19B vs $31.57B market cap).
•BIIB trades at the lower trailing earnings multiple (38.56 vs 105.25 P/E), one valuation lens rather than an overall verdict.
•BIIB converts more revenue to profit (8.39% vs 3.58% net margin).
•WAT grew revenue faster over the past five years (11.70% vs -3.19% CAGR).

Metrics side by side

Valuation

Metric	BIIB	WAT
P/E ratio	38.56	105.25
Forward P/E	17.54	28.96
P/S ratio	3.24	6.80
P/B ratio	1.71	2.08
EV / EBITDA	N/A	39.10
FCF yield	8.38%	1.26%

Profitability

Metric	BIIB	WAT
Gross margin	67.71%	50.78%
Operating margin	12.79%	28.22%
Net margin	8.39%	3.58%
ROE	4.43%	1.09%
ROIC	4.28%	1.34%

Growth (annualized)

Metric	BIIB	WAT
Revenue CAGR (5Y)	-3.19%	11.70%
EPS CAGR (5Y)	-18.67%	5.16%
FCF CAGR (5Y)	-11.63%	-9.10%
Total return CAGR (5Y)	-6.25%	-0.83%

Frequently asked

Which has the lower trailing P/E, BIIB or WAT?: BIIB has the lower trailing P/E: BIIB trades at 38.56 and WAT at 105.25. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIIB or WAT?: Over the past five years, WAT grew revenue faster — BIIB at a -3.19% CAGR versus WAT at 11.70%.
Is BIIB or WAT more profitable?: BIIB runs the higher net margin — BIIB at 8.39% versus WAT at 3.58%.
How have BIIB and WAT total returns compared?: Over the past 10 years, BIIB delivered -3.05% and WAT delivered 10.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full WAT analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio Waters P/E ratio Biogen ROE Waters ROE Biogen operating margin Waters operating margin Biogen revenue growth Waters revenue growth Biogen free cash flow Waters free cash flow

Biogen & Waters appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.